Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy

Abstract

Precision medicine, particularly therapeutic drug monitoring (TDM), is essential for optimizing drug dosage and minimizing toxicity. However, current TDM methods have limitations, including the need for skilled operators, patient discomfort, and the inability to monitor dynamic drug level changes. In recent years, wearable sensors have emerged as a promising solution for drug monitoring. These sensors offer real-time and continuous measurement of drug concentrations in biofluids, enabling personalized medicine and reducing the risk of toxicity. This review provides an overview of drugs detectable by wearable sensors and explores biosensing technologies that can enable drug monitoring in the future. It presents a comparative analysis of multiple biosensing technologies and evaluates their strengths and limitations for integration into wearable detection systems. The promising capabilities of wearable sensors for real-time and continuous drug monitoring offer revolutionary advancements in diagnostic tools, supporting personalized medicine and optimal therapeutic effects. Wearable sensors are poised to become essential components of healthcare systems, catering to the diverse needs of patients and reducing healthcare costs.

Approaches of wearable and implantable biosensor towards of developing in precision medicine

“…Armed with genetic insights, healthcare providers can identify potential health risks long before symptoms manifest. This early detection empowers a proactive approach to healthcare, where interventions can be implemented to prevent the onset of diseases or manage them at their earliest stages ( 9 ). This knowledge allows healthcare professionals to prescribe drugs that are not only effective but also tailored to each patient, minimizing the trial-and-error process often associated with medication regimens.…”

3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations

“…The DBS test extends beyond detection and can be applied to therapeutic dietary and/or pharmacological monitoring (TD/FM), facilitating dose adjustments based on active substance levels [ 50 ]. While TD/FM is crucial for optimizing outcomes and avoiding adverse effects, current methods have limitations, including the need for skilled operators, patient discomfort, and the inability to monitor dynamic drug level changes [ 51 ]. Wearable or portable sensors have emerged as a dynamic solution for real-time and non-invasive therapeutic drug monitoring [ 43 ].…”

Conformable electrochemical devices for closed-loop wound management

“…These integrated closed-loop systems hold immense potential, encompassing diagnosis, early infection warning, treatment effect assessment, and long-term wound management (Liu et al, 2023). Recent years the application of physical treatment (i.g.…”